ArticleRenal failure2024

A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy.

Yi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.